Welcome to GTx, Inc., a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions.

Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development. More...

GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRF’s SARD Drug Technology Read More...

GTx Provides Corporate Update Regarding NASDAQ Stock Listing Read More...

GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results Read More...